BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 36273122)

  • 21. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
    Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
    EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18β-glycyrrhetinic acid promotes gastric cancer cell autophagy and inhibits proliferation by regulating miR-328-3p/signal transducer and activator of transcription 3.
    Yang Y; Nan Y; Du YH; Huang SC; Lu DD; Zhang JF; Li X; Chen Y; Zhang L; Yuan L
    World J Gastroenterol; 2023 Jul; 29(27):4317-4333. PubMed ID: 37545635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncSNHG3 promotes hepatocellular carcinoma epithelial mesenchymal transition progression through the miR-152-3p/JAK1 pathway.
    Li H; Wu Y; Wang R; Guo J; Yu Q; Zhang L; Zhao H; Yang H
    Genes Genomics; 2022 Jan; 44(1):133-144. PubMed ID: 34778942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
    Bai Z; Xia X; Lu J
    Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.
    Wang W; Lin H; Zhou L; Zhu Q; Gao S; Xie H; Liu Z; Xu Z; Wei J; Huang X; Zheng S
    Eur J Surg Oncol; 2014 Nov; 40(11):1586-94. PubMed ID: 24290372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma.
    Zhao L; Wang Y; Liu Q
    Exp Mol Pathol; 2019 Aug; 109():51-60. PubMed ID: 31145886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA 02027 inhibits proliferation, migration and invasion of hepatocellular carcinoma via miR-625-3p/PDLIM5 pathway.
    Wang J; Zhu Y; Ai X; Wan H; Jia W; Chu J; Xu B; Kong X; Kong L
    J Gene Med; 2023 Jun; 25(6):e3485. PubMed ID: 36811210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing PIM-1.
    Qi Y; Yao X; Du X
    IUBMB Life; 2020 Mar; 72(3):452-464. PubMed ID: 31651086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating RNA ZFR promotes hepatocellular carcinoma cell proliferation and epithelial-mesenchymal transition process through miR-624-3p/WEE1 axis.
    Zhang L; He S; Guan H; Zhao Y; Zhang D
    Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):52-63. PubMed ID: 37516591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
    Shi Y; Yan F; Wang F; Pan L
    Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
    Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG
    Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
    Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
    Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
    Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
    Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
    Liu Z; Ouyang G; Lu W; Zhang H
    Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
    Li Y; Bai W; Zhang J
    Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.